Clinical Safety

How Does a Common Fungus Make Cancer More Deadly?
Research & Development How Does a Common Fungus Make Cancer More Deadly?

The microscopic world teeming within the human body harbors countless secrets, with recent discoveries now implicating a common fungus not as a mere passenger but as a sinister co-conspirator in the spread of deadly skin cancer. This revelation challenges conventional understanding by suggesting

How Is Royal Openness Changing Public Health?
Research & Development How Is Royal Openness Changing Public Health?

The British monarchy, an institution historically defined by its stoic reserve, took an unprecedented step in 2024 when both King Charles and Catherine, the Princess of Wales, publicly disclosed their cancer diagnoses, shattering centuries of protocol that shrouded royal health in secrecy. This

Could This Mouse Make Antibody Drugs Safer?
Research & Development Could This Mouse Make Antibody Drugs Safer?

For decades, the path from a promising antibody discovery in the lab to a life-saving therapy for patients has been fraught with uncertainty. Many drugs that show incredible potential in early tests ultimately fail in human trials, costing billions and delaying medical progress. Today we're

Can AI and Genomics Remake Modern Medicine?
Research & Development Can AI and Genomics Remake Modern Medicine?

A profound transformation is sweeping through the halls of biomedical research, driven by the powerful convergence of artificial intelligence and large-scale genomics. This is not merely an incremental improvement on existing methods; it represents a fundamental paradigm shift, moving science from

When Do Our Immune Cells Turn Against Us?
Research & Development When Do Our Immune Cells Turn Against Us?

The human immune system stands as a formidable biological fortress, meticulously designed to identify and annihilate threats ranging from common viruses to nascent cancer cells, but a landmark analysis has illuminated a disturbing scenario where this defense system's own soldiers can be corrupted

How Pharma Can Rebuild Eroding Patient Trust
Research & Development How Pharma Can Rebuild Eroding Patient Trust

The pharmaceutical industry stands at a critical juncture, contending with a deep and persistent deficit of public trust that can significantly impede medical progress and patient care. While this challenge is formidable, it is not an insurmountable barrier to a more collaborative future. Recent

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later